Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

innovation

A collection of 14 Posts

Breakthrough: Wnt Inhibition Overcomes Glioblastoma Immunotherapy Resistance post image

Breakthrough: Wnt Inhibition Overcomes Glioblastoma Immunotherapy Resistance

Flexynesis: AI-Powered Toolkit Enhances Precision Cancer Therapy with Multi-Omics Data post image

Flexynesis: AI-Powered Toolkit Enhances Precision Cancer Therapy with Multi-Omics Data

Metro Hospitals, Noida launches "HeartWise Second Opinion" to guide patients on the right heart treatment post image

Metro Hospitals, Noida launches "HeartWise Second Opinion" to guide patients on the right heart treatment

The Race to Produce Generic Weight-Loss Drugs: China's Pharmaceutical Surge post image

The Race to Produce Generic Weight-Loss Drugs: China's Pharmaceutical Surge

23 of top 50 life sciences companies anchor GCCs in India post image

23 of top 50 life sciences companies anchor GCCs in India

Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain post image

Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain

Latest breakthrough in Type 1 diabetes treatment: Chinese medical team enables 24 patients to discontinue insulin use post image

Latest breakthrough in Type 1 diabetes treatment: Chinese medical team enables 24 patients to discontinue insulin use

New supercharged CAR-T cell therapy shows promise against resistant cancers post image

New supercharged CAR-T cell therapy shows promise against resistant cancers

EndTB-Q trial highlights importance of individualized regimens post image

EndTB-Q trial highlights importance of individualized regimens

New minimally invasive treatment offers hope for primary aldosteronism post image

New minimally invasive treatment offers hope for primary aldosteronism

Sudbury's first hyperbaric oxygen therapy treatment is now available post image

Sudbury's first hyperbaric oxygen therapy treatment is now available

Antengene Announces 2025 Interim Financial Results Highlighting Encouraging Data from Mid/Late-Stage Clinical Programs and Its Innovative TCE Technology Platform post image

Antengene Announces 2025 Interim Financial Results Highlighting Encouraging Data from Mid/Late-Stage Clinical Programs and Its Innovative TCE Technology Platform